Skip to Content

Avalon Globocare Corp ALBT

Morningstar Rating
$0.32 +0.02 (5.79%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ALBT is trading at a 43% discount.
Price
$0.31
Fair Value
$1.26
Uncertainty
Extreme
1-Star Price
$9.83
5-Star Price
$3.66
Economic Moat
Tktm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALBT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.30
Day Range
$0.310.36
52-Week Range
$0.252.45
Bid/Ask
$0.31 / $0.34
Market Cap
$3.52 Mil
Volume/Avg
491,753 / 162,688

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.52
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Sector
Real Estate
Industry
Real Estate Services
Stock Style Box
Small Value
Total Number of Employees
6

Valuation

Metric
ALBT
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
2.52
Price/Cash Flow
Price/Earnings
ALBT

Financial Strength

Metric
ALBT
Quick Ratio
0.07
Current Ratio
0.13
Interest Coverage
−8.76
Quick Ratio
ALBT

Profitability

Metric
ALBT
Return on Assets (Normalized)
−32.43%
Return on Equity (Normalized)
−2,485.77%
Return on Invested Capital (Normalized)
−35.00%
Return on Assets
ALBT
See how this stock stacks up to its competitors with Morningstar Investor

Real Estate Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
CSGP
CoStar Group IncGbmmggdkFpl$39.3 Bil
CBRE
CBRE Group Inc Class AJgtzldjJdfbsr$29.6 Bil
CLLNY
Cellnex Telecom SA ADRQpxwflz$25.1 Bil
CLNXF
Cellnex Telecom SAWddrjyn$25.1 Bil
VNNVF
Vonovia SEWmnxn$24.0 Bil
VONOY
Vonovia SE ADRQbsr$24.0 Bil
VTAGY
Vantage Towers AG ADRHvgzws$20.5 Bil
BEKE
KE Holdings Inc ADRKwtqlrmJswxwzp$17.3 Bil
JLL
Jones Lang LaSalle IncXwnbkzxjGkrqcz$9.2 Bil
CWK
Cushman & Wakefield PLCNrgxmkpZxft$2.3 Bil

Sponsor Center